These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36845983)

  • 1. Medicaid expansion and opioid supply policies to address the opioid overdose crisis.
    Shakya S; Harris SJ
    Drug Alcohol Depend Rep; 2022 Jun; 3():100042. PubMed ID: 36845983
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in Buprenorphine-Naloxone and Opioid Pain Reliever Prescriptions After the Affordable Care Act Medicaid Expansion.
    Saloner B; Levin J; Chang HY; Jones C; Alexander GC
    JAMA Netw Open; 2018 Aug; 1(4):e181588. PubMed ID: 30646116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicaid Prescription Cap Policies: Another Structural Barrier to Medication for Opioid Use Disorder.
    Hughto JMW; Moyo P; Green TC
    J Addict Med; 2022 Nov-Dec 01; 16(6):616-618. PubMed ID: 35245915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of Medicaid expansion on use of opioid agonist treatment and the role of provider capacity constraints.
    Gertner AK; Robertson AG; Jones H; Powell BJ; Silberman P; Domino ME
    Health Serv Res; 2020 Jun; 55(3):383-392. PubMed ID: 32166761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fourth Wave of Opioid (Illicit Drug) Overdose Deaths and Diminishing Access to Prescription Opioids and Interventional Techniques: Cause and Effect.
    Manchikanti L; Singh VM; Staats PS; Trescot AM; Prunskis J; Knezevic NN; Soin A; Kaye AD; Atluri S; Boswell MV; Abd-Elsayed A; Hirsch JA
    Pain Physician; 2022 Mar; 25(2):97-124. PubMed ID: 35322965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Selected State Policies and Requirements for Buprenorphine Treatment With Per Capita Months of Treatment.
    Stein BD; Saloner BK; Golan OK; Andraka-Christou B; Andrews CM; Dick AW; Davis CS; Sheng F; Gordon AJ
    JAMA Health Forum; 2023 May; 4(5):e231102. PubMed ID: 37234015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicaid Expansion and Prescription Trends: Opioids, Addiction Therapies, and Other Drugs.
    Cher BAY; Morden NE; Meara E
    Med Care; 2019 Mar; 57(3):208-212. PubMed ID: 30629018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescription opioid availability and opioid overdose-related mortality rates in Medicaid expansion and non-expansion states.
    Swartz JA; Beltran SJ
    Addiction; 2019 Nov; 114(11):2016-2025. PubMed ID: 31286610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Supply of Physicians Waivered to Prescribe Buprenorphine for Opioid Use Disorders in the United States: A State-Level Analysis.
    Knudsen HK
    J Stud Alcohol Drugs; 2015 Jul; 76(4):644-54. PubMed ID: 26098042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in buprenorphine waivered provider supply after Virginia Medicaid implements the addiction and recovery treatment services program and Medicaid expansion.
    Urmi AF; Britton E; Saunders H; Harrell A; Bachireddy C; Lowe J; Barnes AJ; Cunningham P
    J Subst Use Addict Treat; 2024 Feb; 157():209213. PubMed ID: 37981241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spillover of Medicaid Expansion to Prescribing of Opioid Use Disorder Medications in Medicare Part D.
    Abraham AJ; Lawler EC; Harris SJ; Bagwell Adams G; Bradford WD
    Psychiatr Serv; 2022 Apr; 73(4):418-424. PubMed ID: 34407628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of Medicaid expansion on state-level utilization of buprenorphine for opioid use disorder in the United States.
    Knudsen HK; Hartman J; Walsh SL
    Drug Alcohol Depend; 2022 Mar; 232():109336. PubMed ID: 35123365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicaid Expansion and Availability of Opioid Medications in the Specialty Substance Use Disorder Treatment System.
    Abraham AJ; Yarbrough CR; Harris SJ; Adams GB; Andrews CM
    Psychiatr Serv; 2021 Feb; 72(2):148-155. PubMed ID: 33267651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees.
    Wen H; Hockenberry JM; Pollack HA
    JAMA Netw Open; 2018 Sep; 1(5):e182943. PubMed ID: 30646185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Medicaid Expansion With Opioid Overdose Mortality in the United States.
    Kravitz-Wirtz N; Davis CS; Ponicki WR; Rivera-Aguirre A; Marshall BDL; Martins SS; Cerdá M
    JAMA Netw Open; 2020 Jan; 3(1):e1919066. PubMed ID: 31922561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pill mill laws on opioid overdose deaths in Ohio & Tennessee: A mixed-methods case study.
    Brighthaupt SC; Stone EM; Rutkow L; McGinty EE
    Prev Med; 2019 Sep; 126():105736. PubMed ID: 31152831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in Urine Drug Monitoring Among Persons Receiving Long-Term Opioids and Persons with Opioid Use Disorder in the United States.
    Sohn M; Talbert JC; Huang Z; Oser C; Freeman PR
    Pain Physician; 2021 Mar; 24(2):E249-E256. PubMed ID: 33740362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Medicaid Expansion on Medicaid-covered Utilization of Buprenorphine for Opioid Use Disorder Treatment.
    Wen H; Hockenberry JM; Borders TF; Druss BG
    Med Care; 2017 Apr; 55(4):336-341. PubMed ID: 28296674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Medicaid Expansion on Access to Opioid Analgesic Medications and Medication-Assisted Treatment.
    Sharp A; Jones A; Sherwood J; Kutsa O; Honermann B; Millett G
    Am J Public Health; 2018 May; 108(5):642-648. PubMed ID: 29565661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buprenorphine Use Trends Following Removal of Prior Authorization Policies for the Treatment of Opioid Use Disorder in 2 State Medicaid Programs.
    Keshwani S; Maguire M; Goodin A; Lo-Ciganic WH; Wilson DL; Hincapie-Castillo JM
    JAMA Health Forum; 2022 Jun; 3(6):e221757. PubMed ID: 35977240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.